We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.19% |
| 2 | Miscellaneous | 8.84% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Consumer Staples | 5.73% |
| 5 | Utilities | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
KB Home
KBH
$2.98B
| $591K | 0.01% |
+32,338
| New | +$556K |
|
|
FRTX
552
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $590K | 0.01% |
+159
| New | +$602K |
|
|
ICEL
553
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
| $586K | 0.01% |
35,470
+4,470
| +14% | +$72K |
|
|
HAR
554
DELISTED
Harman International Industries
HAR
| $583K | 0.01% |
+7,120
| New | +$550K |
|
555
Brown & Brown
BRO
$22B
| $578K | 0.01% |
+36,816
| New | +$584K |
|
556
Simon Property Group
SPG
$65.7B
| $578K | 0.01% |
4,038
+1,251
| +45% | +$180K |
|
|
DNY
557
DELISTED
DONNELLEY R R & SONS CO
DNY
| $573K | 0.01% |
28,271
-12,746
| -31% | -$258K |
|
|
PETM
558
DELISTED
PETSMART INC
PETM
| $572K | 0.01% |
+7,865
| New | +$576K |
|
|
DBD
559
DELISTED
Diebold Nixdorf Incorporated
DBD
| $571K | 0.01% |
17,310
+7,429
| +75% | +$232K |
|
560
New York Times
NYT
$11.7B
| $567K | 0.01% |
+35,716
| New | +$486K |
|
561
Fossil Group
FOSL
$315M
| $562K | 0.01% |
+4,686
| New | +$578K |
|
562
Ball Corp
BALL
$16.2B
| $557K | 0.01% |
21,536
-1,236
| -5% | -$30.1K |
|
563
Charles River Laboratories
CRL
$13.1B
| $555K | 0.01% |
10,462
-52,938
| -83% | -$2.66M |
|
564
RPM International
RPM
$12.7B
| $555K | 0.01% |
+13,363
| New | +$520K |
|
565
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
| $554K | 0.01% |
10,000
-10,000
| -50% | -$535K |
|
566
Seagate
STX
$178B
| $552K | 0.01% |
9,832
+3,620
| +58% | +$179K |
|
|
PEO
567
Adams Natural Resources Fund
PEO
$803M
| $550K | 0.01% |
20,901
+275
| +1% | +$7.25K |
|
568
McDonald's
MCD
$176B
| $549K | 0.01% |
5,663
-139,558
| -96% | -$13.4M |
|
|
SPIL
569
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $549K | 0.01% |
+91,810
| New | +$540K |
|
570
Edison International
EIX
$21.1B
| $546K | 0.01% |
11,800
+2,900
| +33% | +$137K |
|
571
Micron Technology
MU
$1.05T
| $542K | 0.01% |
24,889
-2,411
| -9% | -$46.9K |
|
572
Lowe's Companies
LOW
$109B
| $541K | 0.01% |
10,923
+5,383
| +97% | +$262K |
|
573
Fluor
FLR
$7.09B
| $538K | 0.01% |
+6,698
| New | +$511K |
|
574
Dillards
DDS
$10.1B
| $537K | 0.01% |
5,524
+2,805
| +103% | +$243K |
|
575
State Street
STT
$50.2B
| $537K | 0.01% |
7,317
-8,535
| -54% | -$598K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $419M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.